Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Trade Name
Risk Category
  • Positive evidence of human fetal risk exists.
  • Potential benefits may warrant use of the drug in pregnant women despite potential risks (e.g. life threatening situations or serious illness).
The risk category is C in the first trimester.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

  • A systemic angiotensin converting enzyme II inhibitor used for treatment of hypertension.
  • Fetal Risk
    Fetal Risk
  • Fetal expsure during the 2nd or 3rd trimesters can cause hypotension, reversible or irreversible renal failure, anuria, neonatal skull hypoplasia and fetal or neonatal death.
  • Maternal oligohydramnios may be associated with fetal limb contractures, craniofacial deformities and hypoplastic lung development.
  • First trimester exposure is not associated with the previous adverse effects.
  • Breast Feeding
    Breast Feeding
  • There are no adequate studies in women for determining infant risk when using this medication during breastfeeding.
  • Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
  • Other Trade Names
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        Your Friend
     6   +   8    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Month Day Year